Status:
WITHDRAWN
Impact of Methylation Alterations in Colon Cancer: Epidemiology and Prognosis
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Colon Cancer
Eligibility:
All Genders
Brief Summary
We conducted a preliminary study in 2010 using the innovative Illumina GoldenGate (methylation assay) which has enabled us to characterize the level of methylation of 807 potential markers on a series...
Eligibility Criteria
Inclusion
- Adenocarcinomas of the colon (C18) and rectosigmoid junction (C19)
- Resident in Côte-d'Or
- Treated by surgical resection
Exclusion
- Rectal cancer
- Cancer on Crohn's disease and ulcerate colitis
- Hereditary colon cancer (HNPCC, familial polyposis)
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01904968
Start Date
December 1 2011
End Date
December 1 2022
Last Update
March 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Dijon
Dijon, France, 21079